(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that Paul D. Mintz, ... new independent director, effective January 1, 2010. ,, ... transfusion medicine for more than 30 years. He is ... University of Virginia School of Medicine. He also serves ...
(Date:12/16/2009)... -- For wounded U.S. servicemen and women ... D.C., the holidays can be a particularly difficult time. ... rely more than ever on the healing power of ... home just got easier for Walter Reed patients as ... will provide hundreds of minutes of holiday talk time ...
(Date:12/16/2009)... CHICAGO, Dec. 16 HealthSciences Institute ... health care professionals, teams and organizations who ... by, chronic diseases in employer, health plan, ... The collaborative will offer free, noncommercial webinars ... chronic disease prevention, management and care improvement. ...
(Date:12/16/2009)... role in reducing inflammation in the lungs , , WEDNESDAY, ... plays a role in inflammation seems to protect the ... who smoke. , Researchers also found that adult smokers ... lower risk of developing chronic obstructive pulmonary disease (COPD), ... "The gene seems to be protective of the lungs ...
Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Immucor Appoints New Board Director 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3... - Exhibits Growth In All Existing Markets -, ... Bulletin Board: PMQC, PMQCU, PMQCW), the third largest long-term ... served. The,Company experienced growth across all four of its ... in the New York City,metropolitan area, as well as ...
... HCA Inc. announced,today that it had commenced a ... aggregate principal amount of its outstanding debt. The series,of ... offer (the "Notes"),are listed in the table below with ... conditions of the tender offer are described in an,Offer ...
... novel drug designed to lessen muscle damage from a heart ... Research Institute. Results of the study, available online and to ... Circulation, reflect the first time the drug has been tested ... the activity of an enzyme called delta protein kinase C ...
... CHAPEL HILL, N.C., Feb. 7 Selecting and ... a new,challenge for marketing leaders at pharmas and ... share similar,structure, composition, and responsibilities -- all detailed ... Best Practices, LLC., According to research findings, ...
... on Exercise (ACE) Research Proves Dance Dance ... Revolution (DDR) Can Be a Tremendous Workout, SAN DIEGO, ... that eliminate conventional hand controllers in favor of more,full-body interaction, ... to the test., The ACE commissioned research out of ...
... Brings Leading Clean Indoor Air and Health Advocates Together ... Indoor Air Quality, SOUTHBOROUGH, Mass., Feb. 7 Most ... did you know the Environmental,Protection Agency says levels of indoor ... occasionally even 100 times higher -- than outdoor air,pollution levels? ...
Other Medicine News:Health News:Chem Rx Surpasses 65,000 Residents Served 2Health News:HCA Announces Cash Debt Tender Offer 2Health News:HCA Announces Cash Debt Tender Offer 3Health News:HCA Announces Cash Debt Tender Offer 4Health News:HCA Announces Cash Debt Tender Offer 5Health News:HCA Announces Cash Debt Tender Offer 6Health News:Novel compound may lessen heart attack damage 2Health News:Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams 2Health News:Can a Video Game Make Your Kids More Fit? 2Health News:February is Designated as 'National Care About Your Indoor Air' Month 2Health News:February is Designated as 'National Care About Your Indoor Air' Month 3Health News:February is Designated as 'National Care About Your Indoor Air' Month 4(Date:12/16/2009)... -- DATATRAK International, Inc. (OTCQX: DATA), a ... eClinical solutions for the clinical trials industry, ... 9.0 eClinical Software. This release advances ... service delivery and introduces two new mechanisms ... DATATRAK Learning Center(TM) and the DATATRAK Learning ...
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or ... a bridge loan financing (the "2009 Financing") pursuant ... (the "Agreement") with Firebird Global Master Fund, Ltd., ... a convertible promissory note, due June 30, 2010, ... issued a warrant to purchase an aggregate of ...
(Date:12/16/2009)... RealMed has been ranked the ... 2009 Top 20 Best in KLAS ... RealMed is a dynamic revenue cycle management ... between healthcare providers and all ... specializing in vendor performance measurement in the ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3Is hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines 3F 61615 1No muss no fuss miniaturized analysis for complex samples developed 10786 1No muss no fuss miniaturized analysis for complex samples developed 10786 2No muss no fuss miniaturized analysis for complex samples developed 10786 3Extinct moa rewrites New Zealands history 10782 1Extinct moa rewrites New Zealands history 10782 2... high eradication rates for the most common, ... REINACH, Switzerland, Oct. 26 Arpida ... two pivotal Phase III,clinical trials at the ... (ICAAC)/Infectious Diseases Society of America (IDSA) 46th,annual ...
... at ICAAC -, BRIDGEWATER, N.J., Oct. 26 ... 3, randomized, open-label, ongoing clinical,trial showed that 79 ... mg (two 400 mg tablets) with 100 mg ... (<50 copies/mL) at week 96,compared with 71 percent ...
Other Medicine Technology:Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... first microplate spectrophotometer designed specifically to run ... week. With rugged hardware, proven optical performance ... barrier of traditional spectrophotometry to obtain results ... easily read up to eight, 1 cm ...
... The 1100RS Spectrophotometers ... economical. Great for use ... laboratories, including educational, clinical, ... Options include COD vial ...
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
Medicine Products:Biology NavigationMedical Navigation